<DOC>
	<DOCNO>NCT01478126</DOCNO>
	<brief_summary>The purpose study determine whether perioperative glutamine administration possess protective property internal organ ( heart gut ) patient coronary atherosclerosis , operate cardiopulmonary bypass .</brief_summary>
	<brief_title>Effects Glutamine Ischemic Heart Disease Patients Following Cardiopulmonary Bypass</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Adult patient coronary artery disease operate cardiopulmonary bypass Ejection fraction &lt; 40 % Viral hepatitis Liver cirrhosis Cholecystitis Pancreatitis Chronic severe gastrointestinal disease Surgery gastrointestinal tract patient 's medical history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>